Enanta Pharmaceuticals (ENTA) Shareholder's Equity Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.64% |
| Dec 31, 2025 | 13.21% |
| Sep 30, 2025 | -49.76% |
| Jun 30, 2025 | -46.76% |
| Mar 31, 2025 | -43.69% |
| Dec 31, 2024 | -41.73% |
| Sep 30, 2024 | -40.57% |
| Jun 30, 2024 | -37.38% |
| Mar 31, 2024 | -38.33% |
| Dec 31, 2023 | -36.22% |
| Sep 30, 2023 | -32.55% |
| Jun 30, 2023 | -29.64% |
| Mar 31, 2023 | -24.88% |
| Dec 31, 2022 | -21.74% |
| Sep 30, 2022 | -19.55% |
| Jun 30, 2022 | -19.10% |
| Mar 31, 2022 | -17.76% |
| Dec 31, 2021 | -14.96% |
| Sep 30, 2021 | -12.33% |
| Jun 30, 2021 | -13.05% |
| Mar 31, 2021 | -10.28% |
| Dec 31, 2020 | -6.28% |
| Sep 30, 2020 | -1.49% |
| Jun 30, 2020 | 7.24% |
| Mar 31, 2020 | 11.41% |
| Dec 31, 2019 | 12.99% |
| Sep 30, 2019 | 17.48% |
| Jun 30, 2019 | 24.16% |
| Mar 31, 2019 | 30.84% |
| Dec 31, 2018 | 34.40% |
| Sep 30, 2018 | 30.50% |
| Jun 30, 2018 | 38.35% |
| Mar 31, 2018 | 25.33% |
| Dec 31, 2017 | 18.43% |
| Sep 30, 2017 | 11.76% |
| Jun 30, 2017 | -3.03% |
| Mar 31, 2017 | -0.15% |
| Dec 31, 2016 | 1.47% |
| Sep 30, 2016 | 14.30% |
| Jun 30, 2016 | 17.84% |
| Mar 31, 2016 | 18.82% |
| Dec 31, 2015 | 36.43% |
| Sep 30, 2015 | 58.86% |
| Jun 30, 2015 | 49.25% |
| Mar 31, 2015 | 120.43% |
| Dec 31, 2014 | 83.48% |
| Sep 30, 2014 | 34.57% |
| Jun 30, 2014 | 33.69% |
| Mar 31, 2014 | -14.07% |
| Sep 30, 2013 | 195.77% |